|1.||Rosenberg, Gilad: 4 articles (03/2013 - 07/2005)|
|2.||Diener, Hans-Christoph: 3 articles (03/2013 - 06/2008)|
|3.||Kaczmarek, Leszek: 2 articles (02/2014 - 01/2014)|
|4.||Gorelick, Philip B: 2 articles (03/2013 - 08/2011)|
|5.||Shuaib, Ashfaq: 2 articles (03/2013 - 08/2011)|
|6.||Bornstein, Natan: 2 articles (03/2013 - 08/2011)|
|7.||Kozak, Alex: 2 articles (09/2009 - 07/2005)|
|8.||Chaturvedi, Mayank: 1 article (02/2014)|
|9.||Figiel, Izabela: 1 article (01/2014)|
|10.||Yeghiazaryan, Marine: 1 article (01/2014)|
06/01/2008 - "We present the results of a multicenter, double-blind, placebo-controlled, randomized trial to assess the safety and potential protective effects of DP-b99 in acute ischemic stroke. "
03/01/2013 - "Despite encouraging preclinical and phase II trial data, DP-b99 shows no evidence of efficacy in treating human ischemic stroke."
09/15/2009 - "This may underlie the efficacy of DP-b99 in stroke treatment."
03/01/2013 - "The Membrane-Activated Chelator Stroke Intervention trial was a randomized, double-blind, placebo-controlled, multicenter, parallel-group trial of intravenous DP-b99 administered for 4 consecutive days (NCT00893867). "
03/01/2013 - "Results of Membrane-Activated Chelator Stroke Intervention randomized trial of DP-b99 in acute ischemic stroke."
01/01/2014 - "In the present study, we report that DP-b99 delays onset and severity of PTZ-induced seizures in mice, as well as displays neuroprotective effect on kainate excitotoxicity in hippocampal organotypic slices and furthermore blocks morphological reorganization of the dendritic spines evoked by a major neuronal MMP, MMP-9. "
02/01/2014 - "In next part, the literature is organized as various approaches which have proven neuroprotective effects through direct or indirect decrease in MMP-9 activity, namely, using biotherapeutics, involving MMP-9 gene inhibition using viral vectors; using endogenous inhibitor of MMP-9, repurposing of old drugs such as minocycline, new chemical entities like DP-b99, and finally other approaches like therapeutic hypothermia. "
|4.||Craniocerebral Trauma (Head Injury)
|5.||Brain Diseases (Brain Disorder)
|1.||Kainic Acid (Kainate)
|4.||1,2- bis(2- aminophenoxy)ethane- N,N,N',N'- tetraacetic acid (BAPTA)
|2.||Coronary Artery Bypass (Coronary Artery Bypass Surgery)